Gut bacteria sensitive to salt, linked to MS and hypertension: study

a1a5bc34-6901-466f-a77f-9e2770cf085carticleimage.jpg

20 Nov 2017 --- Common salt reduces the number of certain lactic acid bacteria in the gut of mice and humans. This is according to a study published in the journal Nature by Berlin's Max Delbrück Center and Charité, which further notes an impact on immune cells that are partly responsible for autoimmune diseases like multiple sclerosis (MS) and hypertension. Probiotics were also found to ameliorate the symptoms of disease in mice.

We eat salt every day, and we often eat too much, notes the study. “But so far, nobody had studied how salt affects the bacteria in the gut,” says head of the study Professor Dominik Müller of the Berlin Experimental and Clinical Research Center (ECRC) and the Berlin Institute of Health (BIH), both of which are joint institutions within the Max Delbrück Center for Molecular Medicine and the Charité – Universitätsmedizin Berlin.

Lactobacilli work on salt’s harmful effects
Too much salt in food can encourage hypertension and might even have a negative impact on the course of autoimmune diseases like MS. Now Müller and his team have demonstrated that excess salt decimates the lactobacilli in the gut while blood pressure rises and the number of Th17 helper cells is increased. These immune cells are associated with hypertension and autoimmune diseases like MS.

When the animals were given probiotic lactobacilli in addition to the high-salt diet, however, the frequency of Th17 helper cells decreased once again and blood pressure dropped. The probiotics also alleviated the clinical symptoms of experimental autoimmune encephalomyelitis, a disease model for MS.

The researchers thus identified the microbiome as an important factor in diseases affected by salt. “Gut bacteria influence the host organism, and the immune system is also very active in the gut,” says lead author and ECRC scientist Dr. Nicola Wilck.

Müller and Wilck worked together with an interdisciplinary research team including Professor Ralf Linker from FAU Nürnberg-Erlangen, scientists from Massachusetts Institute of Technology (MIT) in Boston, US, from the European Molecular Biology Laboratory (EMBL), Heidelberg, the University of Regensburg and the Vlaams Instituut voor Biotechnologie (VIB) in Hasselt, Belgium. The German Centre for Cardiovascular Research (DZHK) also supported the study.

Pilot study with human test subjects
Apart from the experiments on mice, the researchers also investigated the bacterial community in the digestive tract of 12 healthy men who were given six extra grams of salt every day for two weeks.

As the test subjects otherwise maintained their usual eating habits, they thus roughly doubled their daily intake of salt. Here, too, the lactobacilli responded sensitively. Most of them were no longer detectable after 14 days of increased salt intake. At the same time, scientists discovered that the subjects’ blood pressure rose and the number of Th17 helper cells in the blood increased.

Discoveries could be used for therapy
More and more research is focusing on the role played by bacteria in very different types of diseases. Exactly how the organism interacts with gut flora is still largely unknown, however.

“Our study goes beyond just describing the changes caused by salt. We want to consider interrelated processes,” says Müller. But so far, they have not managed to completely explain the precise interactions; he admits: “We can't exclude the possibility that there are other salt-sensitive bacteria that are just as important.”

Moreover, the study’s new findings have not actually confirmed the therapeutic effect of lactobacilli, which are found in fermented food such as sauerkraut, yogurt and cheese.

“Multiple sclerosis may be one of the salt-sensitive diseases which we might be able to treat in the future with individually-tailored probiotics as add-on to standard immune therapies,” notes neuroimmunologist Professor Ralf Linker. Lactobacillus probiotics of this kind have therapeutic potential.

This will soon all be examined at ECRC, says Wilck: “We are planning a blood pressure study with human subjects: double-blind with a larger number of participants of both genders and placebo-controlled.” After that, the team can start thinking about the therapeutic application of probiotics.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Nutrition & Health News

Weekly Digest: Arla expands fiber yogurt range, probiotics may reduce hay fever symptoms

25 May 2018 --- This week in nutrition news, Arla revealed a new addition to its fiber yogurt range, hoping to boost the UK's daily fiber intake. In research news, probiotic formulations were found to have positive effects on hay fever symptoms, while following a diet high in antioxidants may protect people from the adverse effects of pollution. Furthermore, researchers have made steps in understanding the link between a mothers nutrition during pregnancy and the child's growth, and a study undercovered that consumers are more likely to order unhealthy options when dining out amid louder, ambient music.

Nutrition & Health News

DuPont's probiotic reach expands with Brazilian recognition of health claim

25 May 2018 --- DuPont Nutrition & Health Science has earned approval from the Brazilian Health Regulatory Agency (ANVISA) for its Bifidobacterium lactis HN019 probiotic strain. The regulatory green light marks the recognition of the science behind the strain and allows an on-pack health claim. Customers in Brazil can now bring new probiotic products and dietary supplements faster to market using the first DuPont probiotic to qualify for an approved health claim on the local market.

Nutrition & Health News

Microbiome solutions: A key theme at Vitafoods Europe 2018

24 May 2018 --- Research into the microbiome – the aggregated microbial species in our body – is gaining increasing attention and investment. Although the term is often associated with digestive health, the body, in fact, contains multiple microbiome. This is currently spurring on research and innovation in areas as wide-ranging as women’s health, weight management, immunity and skin health. At Vitafoods Europe 2018, NutritionInsight spoke with suppliers about their efforts and innovations in the microbiome space, using pre or probiotics for gut health and beyond.

Nutrition & Health News

UK sugar reduction efforts fail to reach initial target, industry urged to step up or face tax

23 May 2018 --- The first assessment of the UK government’s sugar reduction program has unveiled failings by industry to reduce sugar in the first year by 5 percent, leading to calls of a sugar tax on sweet treats. The results of the first year have been roundly criticized in the media and described as “hugely disappointing” after Public Health England data revealed that sugar was cut in some categories – sweet spreads and sauces, yogurts and fromage frais and breakfast cereals – while other food groups have fallen short.

Nutrition & Health News

Top companies reflect mixed progress on commitment to global nutrition, ranking shows

23 May 2018 --- Nestlé has nabbed the highest ranking spot in the 2018 Access to Nutrition Index (ATNI), reflecting its overall performance in nutrition-related commitments. Meanwhile, FrieslandCampina has improved the most since 2016, climbing four places in the ranking largely thanks to a new strategy to tackle under-nutrition and more responsible marketing commitments. However, the ATNI state that many companies are still doing too little in the realm of nutrition. The ATNI is the third Global Index that ranks the world’s 22 largest food and beverage companies on their contributions to addressing the twin global nutrition challenges of overweight and diet-related diseases and under-nutrition. 

More Articles
URL : http://www.nutritioninsight.com:80/news/gut-bacteria-sensitive-to-salt-linked-to-ms-and-hypertension-study.html